Open Grant

2026 to 2027 strategic Longer and Larger (sLoLa) outlines: UK bioscience discovery grants

Open 2026/27 BBSRC sLoLa outlines call for large, high-risk team science in bioscience discovery with a minimum full economic cost of GBP 2,000,000 and a two-stage UKRI funding process.

JJ Ben-Joseph, founder of FindMyMoney.App
Reviewed by JJ Ben-Joseph
Official source: UK Research and Innovation (BBSRC)
💰 Funding Minimum award: GBP 2,000,000 (project full economic cost), BBSRC funds 80% of FEC. Total budget …
📅 Deadline Jun 25, 2026
📍 Location United Kingdom
🏛️ Source UK Research and Innovation (BBSRC)

2026 to 2027 strategic Longer and Larger (sLoLa) outlines: UK bioscience discovery grants

The 2026 to 2027 sLoLa outlines funding opportunity is a high-value UK call aimed at curiosity-driven, team-based bioscience discovery projects led by eligible UK organisations. The UK Research and Innovation (UKRI) list for this opportunity shows it as open, with a minimum project scale and a strict deadline: BBSRC must receive outline applications by 25 June 2026 at 4:00pm UK time. The call is explicitly structured as a two-stage process, with full applications only invited after successful outline assessment.

This guide summarizes the official terms on the opportunity page and turns them into practical preparation advice you can use right now.

At a glance

FieldDetail
Opportunity2026 to 2027 strategic Longer and Larger (sLoLa) outlines
FundersBiotechnology and Biological Sciences Research Council (BBSRC), part of UKRI
Funding typeGrant
Minimum project sizeFull economic cost (FEC) at least GBP 2,000,000
UKRI contributionBBSRC funds 80% of FEC
Opening date16 April 2026, 9:00am UK time
Deadline (outline stage)25 June 2026, 4:00pm UK time
Stage 2 timelineExpected November 2026 invitation window, close in February 2027
Start of award activityAnticipated latter half of 2027 to 2028 financial year
DurationUp to 5 years
Key processTwo-stage: outlines first, full submission only by invite
LocationUK organisations
Application systemUKRI Funding Service

What the opportunity is really offering

This is not a small pilot grant. sLoLa is designed for larger, longer, integrated projects that need scale to produce transformational advances in fundamental bioscience. The opportunity text repeatedly frames the programme around ideas that are beyond what several smaller grants can support. The scheme is targeted at conceptual advances and fundamental understanding, not narrow development or incremental project extensions.

The most important practical signal for applicants is the minimum full economic cost threshold of GBP 2,000,000. That number sets an upper bar for ambition and team complexity. Because UKRI sets a minimum, this is often a strategic fit for teams already running coordinated labs across disciplines and institutions.

The page does not publish a fixed programme-level total on the listing, but does state that this round typically awards up to four sLoLa awards subject to application quality and available budget. In practical terms, this means the opportunity can be highly competitive and you should plan for a strong comparative case against other large team-science proposals.

Another useful signal: stage two is explicitly by invitation after outline assessment. That means the outline is not a draft administrative box to tick, it is the gate that determines whether you will even see stage two. The opportunity page says outline applications do not request costs. So the first phase is about scientific integration, scope, and team design, not accounting polish.

What this is best suited for, and when it is not

This call is best suited for groups that can credibly design a project where:

  • breakthroughs require multiple disciplinary approaches,
  • individual parts cannot be cleanly split into independent smaller projects,
  • integration of outputs across teams is essential to scientific impact,
  • and the scale is justifiable in terms of duration and complexity.

The official scope language explicitly excludes work that is primarily end-user service or narrowly applied to short-cycle implementation without strong fundamental science returns. If your project is mainly about product delivery, operational deployment, or incremental process optimization, this may be a weaker match.

The opportunity is also focused on bioscience discovery. The page describes work from molecules to organisms and populations, and prioritises fundamental knowledge and conceptual advances with potential long-term significance. This does not mean applications cannot be near translational, but they should clearly lead from foundational questions to broader biological understanding.

The call is open to teams and is explicit about team science. Standalone applications with weak cross-team logic are unlikely to perform well. The page says your work must remain highly integrated and that application review will expect outputs from a combined effort that are substantively different from isolated efforts by each work package. In practical review terms, this is often where strong projects either win or lose.

Who can apply, and key eligibility details

The call is open to organisations with standard eligibility. The site identifies eligible core institutions as higher education institutions, research council institutes, approved independent research organisations, and public sector research establishments. A single designated project lead must be identified and the project lead is central to administration and accountability.

A useful practical interpretation is to treat the project lead as both scientific and administrative coordinator. UKRI expects clear leadership and shared responsibility for integration, but not a confused leadership model. In this call, the same individual and team should present a coherent structure at outline stage.

Additional eligibility constraints to plan around:

  • Multiple applications with the same project lead are not allowed in the same funding round.
  • Project leads with currently active sLoLa awards are generally not eligible unless the grant is in its final year.
  • Individuals based at international organisations are not eligible as core team members, though international collaborators may still participate as project partners.
  • There is no requirement for prior large-award experience as a project lead; early- and mid-career BBSRC-eligible researchers can lead or co-lead.

The page also adds practical team-operating expectations. You should consider including a grant manager as part of the core team. UKRI explicitly encourages this because long-running, multi-partner grants are operationally demanding, not only scientifically demanding.

The two-stage process: outline first, invitation second

The application route has two mandatory stages. Outline submission is mandatory for all participants and does not request costs at first stage. BBSRC uses this phase to select candidates for full application invitations. Details are expected to be published in November 2026 for stage two specifics.

You should treat this as a serious screening step with a specific output.

For outline stage, the key goal is to demonstrate:

  • fit to scope,
  • team integrity,
  • scientific integration,
  • clear need for scale and duration,
  • and a credible route to producing outcomes bigger than what separate small awards would achieve.

Because costs are not requested at outline, teams should not spend unnecessary time on deep budget narratives yet. They should instead optimize scientific logic and team feasibility under the word-limited and structure-restricted format in the UKRI Funding Service.

For full applications, UKRI funding terms indicate that details are published in November and that the second deadline is expected in February 2027. This aligns with your planning if your team does not receive an invitation this cycle. You should treat full-stage preparation as a conditional workflow: prepare evidence and partner commitments now, but be ready to align with invitation guidance if/when it arrives.

The opportunity states BBSRC must receive outlines by 25 June 2026, and that applications cannot be changed after submission. That reinforces a practical rule: build a final review pass and internal sign-off cycle before clicking submit.

Location, system, and application mechanics you should prepare for now

You must apply via UKRI Funding Service; the page explicitly says the process is not via the older Je-S route. You must have an organisation account set up and be signed in before application can begin.

The official sequence is clear:

  • confirm project lead status,
  • sign in or create a Funding Service account,
  • complete text responses directly in the portal,
  • save progressively and/or work offline where possible,
  • and complete a read-only check before final internal approval.

The page also notes that only the lead research organisation can submit, although team members and partners should contribute content and planning input.

Practical preparation tips for this system:

  1. Set up your Funding Service account early to avoid registration delays close to deadline.
  2. Confirm your internal routes (research office, finance, and compliance) before opening the submission window.
  3. Build one master outline in plain text or controlled documents, then transfer into the portal fields to avoid formatting surprises.
  4. Use strict file size and format rules for any allowed uploads and keep images to permitted contexts only if needed.
  5. Schedule pre-submission read-only review at least one business day before your final deadline.

How this compares to other grant calls you may consider

If you are used to smaller discovery awards or one-line pilot grants, this appears different by design. sLoLa rewards scale, integration, and sustained team work over quick wins. The page states team members should come from diverse backgrounds and institutions where needed, and that collaboration should produce more than a sum of parts.

A practical way to assess fit:

  • If your scientific question can be solved by one lab in one year, this may be too large.
  • If your current teams already coordinate across facilities and disciplines and need major cost and duration to test a unified hypothesis, this may be a strong fit.
  • If your project requires long time-series analysis, shared data infrastructure, or iterative specialist contributions, this environment fits better than many short-cycle calls.

By contrast, projects with a purely incremental objective or those anchored mainly in immediate product commercialization may face stronger scrutiny under the “fundamental understanding” framing. The call language is explicit: it is not mainly for direct applied implementation, even if translational outcomes may eventually flow from the discovery work.

Evidence, planning, and reviewer expectations that matter most

The most important signal from the page is that applications are judged on integration quality and coherence. Reviewers will likely test whether your project truly needs this larger scale and whether it can deliver outcomes impossible through separate smaller projects.

Use the following structure when preparing internal drafts:

  • Strategic case: What major biological question is unresolved today, and why now?
  • Scale case: Why cannot this be done through smaller parallel awards?
  • Team case: Which skills are distributed across institutions, and how are they coordinated?
  • Integration case: How do outputs from each component combine into a transformative result?
  • Delivery case: How will up to five years of activity maintain coherence rather than drift?

The key is not just complexity; it is disciplined complexity. UKRI and BBSRC are explicit that disaggregated projects with weak links can be excluded. So avoid broad lists of aims. Build one story and one set of measurable outcomes.

Also note that the opportunity page includes support guidance on trust, inclusion, and accessibility. Applicants are encouraged to plan for diversity and flexible working, and UKRI indicates disability and accessibility support is available. In many high-value applications this improves institutional readiness, especially around recruitment and governance.

Practical checklist for a compliant outline application

Below is a readiness checklist tied directly to the public terms on the call page.

Core scope check

  • Is the project fundamentally about biological discovery and conceptual advancement?
  • Is the knowledge outcome likely to be broad and long-term in significance?
  • Could your team demonstrate an integrated programme rather than isolated tasks?

Team check

  • Do you have a clearly identified project lead and one primary point of accountability?
  • Are roles of co-leads, specialists, technical staff, and support roles clearly described?
  • Is your team composition sufficiently diverse across methods and institutions?

Scale and duration check

  • Does the project need five years or near this scale?
  • Is the full economic cost at least GBP 2,000,000?
  • Can you defend why the effort cannot be done through smaller funding streams?

Governance check

  • Are institutional roles and decision points clear before submission?
  • Does someone on the team own coordination and documentation?
  • Have you checked institutional internal deadlines and governance steps?

Submission mechanics check

  • Funding Service account ready and verified,
  • internal partner contributions captured in draft text,
  • draft reviewed in read-only mode,
  • compliance with image and upload rules, and
  • final submission done before the 25 June 2026 close.

Common mistakes that can weaken a strong proposal

Given the format and timeline, teams often fail in predictable ways.

  • Treating outline stage like a full grant write-up: costs are not requested at this stage, so overinvesting in budget detail can waste space and reduce clarity.
  • Proposing a team that looks large but fragmented: if the integration logic is weak, reviewers are likely to question the scale claim.
  • Ignoring the no-duplication rule: multiple applications with the same lead in the same round are not allowed.
  • Assuming no international partners are possible: international organisations can still participate as project partners, but cannot sit as core team members unless eligibility conditions are met.
  • Missing internal institutional routing: the page states final responsibility for compliance remains with the applicant, so institutional checks are your risk control, not a courtesy.
  • Delaying the Funding Service set-up: late account/setup problems can create avoidable technical delays.
  • Treating stage two as guaranteed: invitations are by assessment and not all outline submissions proceed.

A small but important issue from the opportunity terms is the note on sensitive information. If something relevant for eligibility or reviewer assignment should remain confidential, the page gives a designated contact email. Build this into your internal process so teams do not over-disclose sensitive facts in publicly visible sections.

FAQ

Is this an individual fellowship or a team award?

This opportunity is team-oriented and oriented around multi-partner, multi-institution team science for bioscience discovery.

Is full matched funding required from host institutions?

Beyond the standard 20% FEC, the page says no additional matched-funding requirement is imposed for this opportunity. Direct and in-kind partner contributions are encouraged.

Can international collaborators be included?

Yes, as project partners. Core team membership is constrained by eligibility rules.

Is the award size fixed?

The listing confirms only a minimum threshold. Exact total award and full budget details are not fixed to a single public cap in this listing text.

When can full application documents be submitted?

The published text says invited applicants should expect stage two invitation details in November 2026, with a closure expected in February 2027.

Which application route is used?

You must use the UKRI Funding Service. The page explicitly says Je-S is not used for this opportunity.

Why this opportunity may be particularly strategic in 2026/2027

This timeline is strategic for planning. The outline closes in June 2026, with possible full-stage closure in February 2027. That means teams can use current momentum to submit a strong outline this cycle, then either move forward if invited or retool around official stage-two feedback cycles.

For institutions building 2026/27 research pipelines, this also aligns with planning around FY 2027 to 2028 launch. The page indicates awarded projects are anticipated to start in the latter half of that financial period. So if you are planning hiring, equipment planning, or multi-site integration, this can work as a forward-looking anchor.

Because the review standard is tightly connected to integration and scale, teams should avoid the common trap of presenting a large budget as proof of impact. Impact here is about conceptual novelty, robust coordination, and scientific coherence across teams over time.

Official source page: 2026 to 2027 strategic Longer and Larger (sLoLa) outlines

Supporting official channels for applicants include the UKRI Funding Service and BBSRC contact points listed on the opportunity page. If you need fit-to-scope confirmation, the page provides BBSRC support contact details for pre-submission questions.

Recommended immediate actions:

  1. Confirm your core team and single project lead.
  2. Map a one-page integration logic showing why this scale is necessary.
  3. Build and confirm internal governance and funding-service account status.
  4. Draft outline text against two criteria: scientific integration and justification for longer and larger scale.
  5. Complete internal read-only verification before submission by June 2026.
Next step
Apply Now